Clinical Trial Update: Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

An update on the ABBV-6628 intravitreal study in adults with geographic atrophy due to age-related macular degeneration, focusing on adverse events and pharmaco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• ABBV-6628

Snippet

Sponsor: AbbVie | Conditions: Geographic Atrophy, Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING